Literature DB >> 12792381

Neonatal meningococcal disease in the United States, 1990 to 1999.

Colin W Shepard1, Nancy E Rosenstein, Marc Fischer.   

Abstract

BACKGROUND: Although neonatal bacterial meningitis is common, the rate of invasive meningococcal disease in the United States among children < or =30 days old has not been defined. Most relevant literature consists of case reports or case series, which note high case-fatality ratios but do not describe the overall burden of disease.
METHODS: We used active, population-based surveillance data from the Active Bacterial Core Surveillance program to estimate the incidence of neonatal meningococcal disease in the United States from 1990 to 1999. A case of neonatal meningococcal disease was defined as isolation of Neisseria meningitidis from a normally sterile site in a resident of the surveillance area < or =30 days of age.
RESULTS: The median annual number of neonates under surveillance was 25 900. Between 1990 and 1999, 22 cases of neonatal meningococcal disease were identified. Three (14%) patients died. The average annual incidence was 9 per 100 000.
CONCLUSIONS: The rate of neonatal meningococcal disease in the United States is higher than previous estimates. Meningococcal disease is uncommon in neonates, but its rate is similar to that of meningococcal disease in 6- to 23-month-old children.

Entities:  

Mesh:

Year:  2003        PMID: 12792381     DOI: 10.1097/01.inf.0000066876.77453.04

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  11 in total

1.  Population snapshot of invasive serogroup B meningococci in South Africa from 2005 to 2008.

Authors:  Mignon du Plessis; Chivonne Moodley; Kedibone M Mothibeli; Azola Fali; Keith P Klugman; Anne von Gottberg
Journal:  J Clin Microbiol       Date:  2012-05-16       Impact factor: 5.948

Review 2.  Review of meningococcal group B vaccines.

Authors:  Dan M Granoff
Journal:  Clin Infect Dis       Date:  2010-03-01       Impact factor: 9.079

Review 3.  Does binding of complement factor H to the meningococcal vaccine antigen, factor H binding protein, decrease protective serum antibody responses?

Authors:  Dan M Granoff; Sanjay Ram; Peter T Beernink
Journal:  Clin Vaccine Immunol       Date:  2013-06-05

Review 4.  Neisseria meningitidis: biology, microbiology, and epidemiology.

Authors:  Nadine G Rouphael; David S Stephens
Journal:  Methods Mol Biol       Date:  2012

5.  Naturally acquired passive protective activity against Neisseria meningitidis Group C in the absence of serum bactericidal activity.

Authors:  Jo Anne Welsch; Dan Granoff
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

6.  An unusual case of meningococcal meningitis complicated with subdural empyema in a 3 month old infant: a case report.

Authors:  Kawai Yip; Roly D Gosling; Victoria Jones; Ian K Hosein
Journal:  Cases J       Date:  2009-09-17

Review 7.  Neonatal infection with Neisseria meningitidis: analysis of a 97-year period plus case study.

Authors:  Evrim Kiray Baş; Ali Bülbül; Serdar Cömert; Sinan Uslu; Selda Arslan; Asiye Nuhoglu
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

Review 8.  The changing epidemiology of meningococcal disease in North America 1945-2010.

Authors:  Carmen Baccarini; Andrew Ternouth; Heather Wieffer; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

9.  Neisseria Meningitidis Causing Multiple Cerebral Abscesses in Early Neonatal Period: Case Report and Review of Literature.

Authors:  Laxman Basani; Roja Aepala
Journal:  J Clin Diagn Res       Date:  2017-07-01

10.  Characteristics of Intracranial Group A Streptococcal Infections in US Children, 1997-2014.

Authors:  Ruth Link-Gelles; Karrie-Ann Toews; William Schaffner; Kathryn M Edwards; Carolyn Wright; Bernard Beall; Brenda Barnes; Brenda Jewell; Lee H Harrison; Pam D Kirley; Lauren Lorentzson; Deborah Aragon; Susan Petit; Joseph Bareta; Nancy L Spina; Paul R Cieslak; Chris Van Beneden
Journal:  J Pediatric Infect Dis Soc       Date:  2020-02-28       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.